Insider Transactions
| Date | Name | Title | Type | Shares Traded | Price Range |
|---|---|---|---|---|---|
| Apr 07, 2021 |
Director
|
Director | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 20,000 | $3.15 |
| Apr 06, 2021 |
Chief Medical Officer
|
Chief Medical Officer | Open market or private sale of non-derivative or derivative security | 1,025 | $3.24 |
| Apr 06, 2021 |
Chief Medical Officer
|
Chief Medical Officer | Other acquisition or disposition | -- | -- |
| Apr 05, 2021 |
Chief Medical Officer
|
Chief Medical Officer | Open market or private sale of non-derivative or derivative security | 1,125 | $3.31 |
| Apr 01, 2021 |
Chief Legal Officer
|
Chief Legal Officer | Open market or private sale of non-derivative or derivative security | 2,200 | $3.30 |
| Apr 01, 2021 |
Chief Legal Officer
|
Chief Legal Officer | Other acquisition or disposition | -- | -- |
| Mar 31, 2021 |
Chief Legal Officer
|
Chief Legal Officer | Open market or private sale of non-derivative or derivative security | 1,739 | $3.20 |
| Mar 17, 2021 |
EVP & Chief Financial Officer
|
EVP & Chief Financial Officer | Other acquisition or disposition | -- | -- |
| Mar 17, 2021 |
Chief Medical Officer
|
Chief Medical Officer | Other acquisition or disposition | -- | -- |
| Mar 17, 2021 |
Chief Legal Officer
|
Chief Legal Officer | Other acquisition or disposition | -- | -- |
| Mar 17, 2021 |
EVP, COO & CCO
|
EVP, COO & CCO | Other acquisition or disposition | -- | -- |
| Mar 17, 2021 |
Director, CEO & President
|
Director, CEO & President | Other acquisition or disposition | -- | -- |
| Mar 16, 2021 |
EVP & Chief Financial Officer
|
EVP & Chief Financial Officer | Open market or private sale of non-derivative or derivative security | 16,318 | $3.69 |
| Mar 16, 2021 |
Chief Medical Officer
|
Chief Medical Officer | Open market or private sale of non-derivative or derivative security | 18,828 | $3.69 |
| Mar 16, 2021 |
Chief Legal Officer
|
Chief Legal Officer | Open market or private sale of non-derivative or derivative security | 16,318 | $3.69 |
| Mar 16, 2021 |
EVP, COO & CCO
|
EVP, COO & CCO | Open market or private sale of non-derivative or derivative security | 18,828 | $3.69 |
| Mar 16, 2021 |
Director, CEO & President
|
Director, CEO & President | Open market or private sale of non-derivative or derivative security | 28,243 | $3.69 |
| Mar 15, 2021 |
EVP & Chief Financial Officer
|
EVP & Chief Financial Officer | Open market or private sale of non-derivative or derivative security | 20,365 | $3.62 |
| Mar 15, 2021 |
Chief Medical Officer
|
Chief Medical Officer | Open market or private sale of non-derivative or derivative security | 22,631 | $3.62 |
| Mar 15, 2021 |
Chief Legal Officer
|
Chief Legal Officer | Open market or private sale of non-derivative or derivative security | 14,362 | $3.62 |
| Mar 15, 2021 |
EVP, COO & CCO
|
EVP, COO & CCO | Open market or private sale of non-derivative or derivative security | 23,291 | $3.62 |
| Mar 15, 2021 |
Director, CEO & President
|
Director, CEO & President | Open market or private sale of non-derivative or derivative security | 40,091 | $3.62 |
| Feb 24, 2021 |
Chief Medical Officer
|
Chief Medical Officer | Other acquisition or disposition | -- | -- |
| Feb 23, 2021 |
EVP & Chief Financial Officer
|
EVP & Chief Financial Officer | Other acquisition or disposition | -- | -- |
| Feb 23, 2021 |
Chief Legal Officer
|
Chief Legal Officer | Other acquisition or disposition | -- | -- |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.